#begin document (nw/wsj/19/wsj_1904); part 000
nw/wsj/19/wsj_1904   0    0       Britain    NNP   (TOP(S(NP(NP*          -    -   -   -     (GPE)       (ARG0*        *   (ARG0*      *        *   -
nw/wsj/19/wsj_1904   0    1            's    POS               *)         -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0    2    Monopolies   NNPS           (NML*          -    -   -   -    (ORG*             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0    3           and     CC               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0    4       Mergers   NNPS               *)         -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0    5    Commission    NNP               *)         -    -   -   -        *)            *)       *        *)     *        *   -
nw/wsj/19/wsj_1904   0    6     Wednesday    NNP            (NP*)         -    -   -   -    (DATE)   (ARGM-TMP*)       *        *      *        *   -
nw/wsj/19/wsj_1904   0    7       cleared    VBD            (VP*       clear  02   3   -        *           (V*)       *        *      *        *   -
nw/wsj/19/wsj_1904   0    8         Rhone    NNP      (NP(NP(NP*          -    -   -   -    (ORG*        (ARG1*   (ARG0*        *      *        *   -
nw/wsj/19/wsj_1904   0    9            -    HYPH               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   10       Poulenc    NNP               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   11          S.A.    NNP               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   12            's    POS               *)         -    -   -   -        *)            *        *)       *      *        *   -
nw/wsj/19/wsj_1904   0   13      purchase     NN               *)   purchase  01   1   -        *             *      (V*)       *      *        *   -
nw/wsj/19/wsj_1904   0   14            of     IN            (PP*          -    -   -   -        *             *   (ARG1*        *      *        *   -
nw/wsj/19/wsj_1904   0   15             a     DT            (NP*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   16     specialty     NN               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   17          bulk     JJ           (NML*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   18            -    HYPH               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   19      chemical     NN               *)         -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   20          unit     NN              *))         -    -   -   -        *             *        *)       *      *        *   -
nw/wsj/19/wsj_1904   0   21          from     IN            (PP*          -    -   -   -        *             *   (ARG2*        *      *        *   -
nw/wsj/19/wsj_1904   0   22      Monsanto    NNP            (NP*          -    -   -   -    (ORG*             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   23           Co.    NNP             *)))         -    -   -   -        *)            *)       *)       *      *        *   -
nw/wsj/19/wsj_1904   0   24             ,      ,               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   25        saying    VBG          (S(VP*         say  01   -   -        *    (ARGM-ADV*        *      (V*)     *        *   -
nw/wsj/19/wsj_1904   0   26           the     DT     (SBAR(S(NP*          -    -   -   -        *             *        *   (ARG1*      *   (ARG1*   -
nw/wsj/19/wsj_1904   0   27      purchase     NN               *)   purchase  01   1   -        *             *        *        *    (V*)       *)  -
nw/wsj/19/wsj_1904   0   28           was    VBD            (VP*          be  01   -   -        *             *        *        *      *      (V*)  -
nw/wsj/19/wsj_1904   0   29      unlikely     JJ          (ADJP*          -    -   -   -        *             *        *        *      *   (ARG2*   -
nw/wsj/19/wsj_1904   0   30            to     TO          (S(VP*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   31          have     VB            (VP*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   32           any     DT         (NP(NP*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   33       lasting     JJ               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   34        impact     NN               *)         -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   35            on     IN            (PP*          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   36          U.K.    NNP            (NP*          -    -   -   -     (GPE)            *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   37    industrial     JJ               *          -    -   -   -        *             *        *        *      *        *   -
nw/wsj/19/wsj_1904   0   38     consumers    NNS   *)))))))))))))         -    -   -   -        *             *)       *        *)     *        *)  -
nw/wsj/19/wsj_1904   0   39             .      .              *))         -    -   -   -        *             *        *        *      *        *   -

nw/wsj/19/wsj_1904   0    0             The     DT     (TOP(S(NP(NP*        -    -   -   -        *         *   (ARG0*         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    1      commission     NN                 *)       -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    2               ,      ,                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    3           which    WDT       (SBAR(WHNP*)       -    -   -   -        *    (ARG0*)       *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    4             was    VBD            (S(VP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    5           asked    VBN              (VP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    6              to     TO            (S(VP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    7           study     VB              (VP*     study  01   -   -        *       (V*)       *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    8             the     DT              (NP*        -    -   -   -        *    (ARG1*        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0    9            deal     NN              *))))       -    -   -   -        *         *)       *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   10              by     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   11             the     DT           (NP(NP*        -    -   -   -    (ORG*         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   12      Department    NNP                 *)       -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   13              of     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   14           Trade    NNP              (NP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   15             and     CC                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   16        Industry    NNP              *))))       -    -   -   -        *)        *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   17           after     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   18             its   PRP$           (NP(NP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   19    announcement     NN                 *)       -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   20              in     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   21        February    NNP       (NP*))))))))       -    -   -   -    (DATE)        *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   22               ,      ,                 *)       -    -   -   -        *         *        *)        *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   23            said    VBD              (VP*       say  01   -   -        *         *      (V*)        *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   24             the     DT    (SBAR(S(NP(NP*        -    -   -   -        *         *   (ARG1*         *        *   (ARG1*   (ARG2*             *   -
nw/wsj/19/wsj_1904   0   25       diversity     NN                 *)       -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   26              of     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   27          global     JJ           (NP(NP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   28          supply     NN                 *)       -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   29              of     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   30       chemicals    NNS           (NP(NP*)       -    -   -   -        *         *        *    (ARG1*)       *        *        *             *   -
nw/wsj/19/wsj_1904   0   31            used    VBN              (VP*       use  01   -   -        *         *        *       (V*)       *        *        *             *   -
nw/wsj/19/wsj_1904   0   32              in     IN              (PP*        -    -   -   -        *         *        *    (ARG2*        *        *        *             *   -
nw/wsj/19/wsj_1904   0   33          making    VBG            (S(VP*      make  01   -   -        *         *        *         *      (V*)       *        *             *   -
nw/wsj/19/wsj_1904   0   34       analgesic     JJ              (NP*        -    -   -   -        *         *        *         *   (ARG1*        *        *             *   -
nw/wsj/19/wsj_1904   0   35           drugs    NNS        *))))))))))       -    -   -   -        *         *        *         *)       *)       *)       *)            *   -
nw/wsj/19/wsj_1904   0   36             was    VBD              (VP*        be  01   -   -        *         *        *         *        *      (V*)       *             *   -
nw/wsj/19/wsj_1904   0   37           great     JJ            (ADJP*        -    -   -   -        *         *        *         *        *   (ARG2*        *             *   -
nw/wsj/19/wsj_1904   0   38          enough     RB                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   39              to     TO            (S(VP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   40          offset     VB              (VP*    offset  01   1   -        *         *        *         *        *        *      (V*)            *   -
nw/wsj/19/wsj_1904   0   41             the     DT           (NP(NP*        -    -   -   -        *         *        *         *        *        *   (ARG1*        (ARG1*   -
nw/wsj/19/wsj_1904   0   42        dominant     JJ                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   43            U.K.    NNP                 *        -    -   -   -     (GPE)        *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   44          market     NN                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   45           share     NN                 *)       -    -   -   -        *         *        *         *        *        *        *             *)  -
nw/wsj/19/wsj_1904   0   46           Rhone    NNP       (SBAR(S(NP*        -    -   -   -    (ORG*         *        *         *        *        *        *        (ARG0*   -
nw/wsj/19/wsj_1904   0   47              -    HYPH                 *        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   48         Poulenc    NNP                 *)       -    -   -   -        *)        *        *         *        *        *        *             *)  -
nw/wsj/19/wsj_1904   0   49           would     MD              (VP*        -    -   -   -        *         *        *         *        *        *        *    (ARGM-MOD*)  -
nw/wsj/19/wsj_1904   0   50            gain     VB              (VP*      gain  02   -   -        *         *        *         *        *        *        *           (V*)  -
nw/wsj/19/wsj_1904   0   51         through     IN              (PP*        -    -   -   -        *         *        *         *        *        *        *        (ARG2*   -
nw/wsj/19/wsj_1904   0   52             the     DT              (NP*        -    -   -   -        *         *        *         *        *        *        *             *   -
nw/wsj/19/wsj_1904   0   53     acquisition     NN   *)))))))))))))))       -    -   -   -        *         *        *)        *        *        *)       *)            *)  -
nw/wsj/19/wsj_1904   0   54               .      .                *))       -    -   -   -        *         *        *         *        *        *        *             *   -

nw/wsj/19/wsj_1904   0    0           The    DT  (TOP(S(NP*      -    -   -   -           *        (ARG0*   -
nw/wsj/19/wsj_1904   0    1        French   NNP           *      -    -   -   -       (NORP)            *   -
nw/wsj/19/wsj_1904   0    2      chemical    NN           *      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0    3         giant    NN           *)     -    -   -   -           *             *)  -
nw/wsj/19/wsj_1904   0    4         would    MD        (VP*      -    -   -   -           *    (ARGM-MOD*)  -
nw/wsj/19/wsj_1904   0    5          hold    VB        (VP*    hold  01   -   -           *           (V*)  -
nw/wsj/19/wsj_1904   0    6            an    DT     (NP(NP*      -    -   -   -           *        (ARG1*   -
nw/wsj/19/wsj_1904   0    7           80     CD       (NML*      -    -   -   -   (PERCENT*             *   -
nw/wsj/19/wsj_1904   0    8             %    NN           *)     -    -   -   -           *)            *   -
nw/wsj/19/wsj_1904   0    9         share    NN           *)     -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   10            of    IN        (PP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   11           the    DT     (NP(NP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   12          U.K.   NNP           *      -    -   -   -        (GPE)            *   -
nw/wsj/19/wsj_1904   0   13        market    NN           *)     -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   14           for    IN        (PP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   15     salicylic    JJ     (NP(NP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   16          acid    NN           *)     -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   17             ,     ,           *      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   18        methyl    NN        (NP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   19    salicylate    NN           *)     -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   20           and    CC           *      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   21          bulk    JJ        (NP*      -    -   -   -           *             *   -
nw/wsj/19/wsj_1904   0   22       aspirin    NN    *))))))))     -    -   -   -           *             *)  -
nw/wsj/19/wsj_1904   0   23             .     .          *))     -    -   -   -           *             *   -

nw/wsj/19/wsj_1904   0    0             The     DT    (TOP(S(NP*         -    -   -   -        *   (ARG0*        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    1      commission     NN             *)        -    -   -   -        *        *)       *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    2           found    VBD          (VP*       find  01   -   -        *      (V*)       *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    3            that     IN        (SBAR*         -    -   -   -        *   (ARG1*        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    4              if     IN      (S(SBAR*         -    -   -   -        *        *        *        *    (ARGM-ADV*        *         *        *   -
nw/wsj/19/wsj_1904   0    5             the     DT        (S(NP*         -    -   -   -        *        *   (ARG0*   (ARG0*             *        *         *        *   -
nw/wsj/19/wsj_1904   0    6         British     JJ             *         -    -   -   -    (NORP)       *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    7      government     NN             *)        -    -   -   -        *        *        *)       *)            *        *         *        *   -
nw/wsj/19/wsj_1904   0    8       attempted    VBD          (VP*    attempt  01   -   -        *        *      (V*)       *             *        *         *        *   -
nw/wsj/19/wsj_1904   0    9              to     TO        (S(VP*         -    -   -   -        *        *   (ARG1*        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   10           block     VB          (VP*      block  01   2   -        *        *        *      (V*)            *        *         *        *   -
nw/wsj/19/wsj_1904   0   11             the     DT          (NP*         -    -   -   -        *        *        *   (ARG1*             *        *         *        *   -
nw/wsj/19/wsj_1904   0   12          merger     NN       *)))))))        -    -   -   -        *        *        *)       *)            *)       *         *        *   -
nw/wsj/19/wsj_1904   0   13               ,      ,             *         -    -   -   -        *        *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   14           Rhone    NNP          (NP*         -    -   -   -    (ORG*        *        *        *        (ARG0*   (ARG0*         *   (ARG0*   -
nw/wsj/19/wsj_1904   0   15              -    HYPH             *         -    -   -   -        *        *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   16         Poulenc    NNP             *)        -    -   -   -        *)       *        *        *             *)       *)        *        *)  -
nw/wsj/19/wsj_1904   0   17           would     MD          (VP*         -    -   -   -        *        *        *        *    (ARGM-MOD*)       *         *        *   -
nw/wsj/19/wsj_1904   0   18          likely     RB        (ADVP*)        -    -   -   -        *        *        *        *    (ARGM-ADV*)       *         *        *   -
nw/wsj/19/wsj_1904   0   19         respond     VB          (VP*    respond  01   -   -        *        *        *        *           (V*)       *         *        *   -
nw/wsj/19/wsj_1904   0   20              by     IN          (PP*         -    -   -   -        *        *        *        *        (ARG2*        *         *        *   -
nw/wsj/19/wsj_1904   0   21         closing    VBG        (S(VP*      close  01   -   -        *        *        *        *             *      (V*)        *        *   -
nw/wsj/19/wsj_1904   0   22             the     DT       (NP(NP*         -    -   -   -        *        *        *        *             *   (ARG1*    (ARG1*        *   -
nw/wsj/19/wsj_1904   0   23     salicylates    NNS             *         -    -   -   -        *        *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   24           plant     NN             *)        -    -   -   -        *        *        *        *             *        *         *)       *   -
nw/wsj/19/wsj_1904   0   25        Monsanto    NNP   (SBAR(S(NP*)        -    -   -   -     (ORG)       *        *        *             *        *    (ARG0*)       *   -
nw/wsj/19/wsj_1904   0   26        operates    VBZ        (VP*)))   operate  01   -   -        *        *        *        *             *        *       (V*)       *   -
nw/wsj/19/wsj_1904   0   27              in     IN          (PP*         -    -   -   -        *        *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   28           Wales    NNP     (NP*))))))        -    -   -   -     (GPE)       *        *        *             *)       *)        *        *   -
nw/wsj/19/wsj_1904   0   29               ,      ,             *         -    -   -   -        *        *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   30        removing    VBG        (S(VP*     remove  01   -   -        *        *        *        *    (ARGM-ADV*        *         *      (V*)  -
nw/wsj/19/wsj_1904   0   31             the     DT          (NP*         -    -   -   -        *        *        *        *             *        *         *   (ARG1*   -
nw/wsj/19/wsj_1904   0   32          matter     NN             *)        -    -   -   -        *        *        *        *             *        *         *        *)  -
nw/wsj/19/wsj_1904   0   33            from     IN          (PP*         -    -   -   -        *        *        *        *             *        *         *   (ARG2*   -
nw/wsj/19/wsj_1904   0   34            U.K.    NNP          (NP*         -    -   -   -     (GPE)       *        *        *             *        *         *        *   -
nw/wsj/19/wsj_1904   0   35    jurisdiction     NN     *)))))))))        -    -   -   -        *        *)       *        *             *)       *         *        *)  -
nw/wsj/19/wsj_1904   0   36               .      .            *))        -    -   -   -        *        *        *        *             *        *         *        *   -

#end document
